SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001213900-21-011728
Filing Date
2021-02-25
Accepted
2021-02-25 17:30:31
Documents
4

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT fs12021_orionbiotech.htm S-1 3103113
2 CONSENT OF WITHUMSMITH+BROWN, PC fs12021ex23-1_orionbiotech.htm EX-23.1 2499
3 CONSENT OF DIRECTOR NOMINEE - SAMUEL BRODER fs12021ex99-1_orionbiotech.htm EX-99.1 2578
4 CONSENT OF DIRECTOR NOMINEE - JAMES COLLINS fs12021ex99-2_orionbiotech.htm EX-99.2 2503
  Complete submission text file 0001213900-21-011728.txt   3111553
Mailing Address 645 FIFTH AVENUE, 21ST FLOOR NEW YORK NY 10022
Business Address 645 FIFTH AVENUE, 21ST FLOOR NEW YORK NY 10022 212-303-7822
Orion Biotech Opportunities Corp. (Filer) CIK: 0001847416 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-253548 | Film No.: 21682002